Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)
Observational Prospective Cohort Study - Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)
Sponsor: Enrollme.ru, LLC
Listed as NCT04422470, this observational or N/A phase trial focuses on Coronavirus Infection and Hematologic Diseases and remains completed. Sponsored by Enrollme.ru, LLC, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2021 — Feb 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Dec 2020 [monthly]
Recruiting
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Enrollme.ru, LLC
- Foundation for Cancer Research Support (RakFond)
- National Research Center for Hematology, Russia
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Kazan', Russia , Moscow, Russia , Nizhny Novgorod, Russia , Novosibirsk, Russia , Omsk, Russia , Saint Petersburg, Russia , Saransk, Russia , Ulan-Ude, Russia , Vladimir, Russia , Vladivostok, Russia and 2 more locations